Nutex Health (NASDAQ:NUTX – Get Free Report) was upgraded by equities researchers at Zacks Research to a “hold” rating in a report issued on Monday,Zacks.com reports.
Several other analysts also recently issued reports on the stock. B. Riley Financial assumed coverage on shares of Nutex Health in a research report on Friday, June 26th. They issued a “buy” rating and a $290.00 price objective for the company. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Lake Street Capital initiated coverage on Nutex Health in a research note on Tuesday, June 2nd. They set a “buy” rating and a $235.00 target price for the company. Finally, Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Nutex Health currently has an average rating of “Moderate Buy” and an average price target of $243.33.
Read Our Latest Stock Report on Nutex Health
Nutex Health Price Performance
Nutex Health (NASDAQ:NUTX – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $6.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. The firm had revenue of $216.49 million for the quarter, compared to analyst estimates of $227.80 million. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. Equities analysts predict that Nutex Health will post 22.72 earnings per share for the current year.
Institutional Investors Weigh In On Nutex Health
A number of institutional investors have recently modified their holdings of NUTX. Islay Capital Management LLC bought a new position in Nutex Health in the fourth quarter worth about $34,000. BNP Paribas Financial Markets boosted its holdings in shares of Nutex Health by 966.7% during the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after acquiring an additional 290 shares during the period. Royal Bank of Canada grew its position in shares of Nutex Health by 752.4% during the fourth quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after acquiring an additional 316 shares during the last quarter. Bank of America Corp DE increased its holdings in shares of Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after acquiring an additional 2,043 shares during the period. Finally, EverSource Wealth Advisors LLC acquired a new stake in shares of Nutex Health in the 1st quarter worth about $83,000. Institutional investors own 5.32% of the company’s stock.
About Nutex Health
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Read More
- Five stocks we like better than Nutex Health
- Short Squeeze Alert—Moderna Stock Surges on New Strategy
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
